{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:15:52Z","timestamp":1790813752032,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T00:00:00Z","timestamp":1387324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084585","type":"journal-article","created":{"date-parts":[[2013,12,18]],"date-time":"2013-12-18T22:39:15Z","timestamp":1387406355000},"page":"e84585","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Incidence of Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Impact on Patient Outcome"],"prefix":"10.1371","volume":"8","author":[{"given":"Maryline","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilesh V.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabete","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Verhoustraten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Calmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh B.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Michon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","article-title":"Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis","volume":"6","author":"A Gupta","year":"2011","journal-title":"PLOS ONE"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e55824","DOI":"10.1371\/journal.pone.0055824","article-title":"Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa","volume":"8","author":"A Gupta","year":"2013","journal-title":"PLOS ONE"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/infdis\/jir411","article-title":"Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis","volume":"204","author":"SD Lawn","year":"2011","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e15241","DOI":"10.1371\/journal.pone.0015241","article-title":"The effect of tuberculosis on mortality in HIV positive people: a meta-analysis","volume":"5","author":"M Straetemans","year":"2010","journal-title":"PLOS ONE"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14740338.2011.546783","article-title":"Initiating antiretrovirals during tuberculosis treatment: a drug safety review","volume":"10","author":"TN Gengiah","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"SS Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"365","author":"FX Blanc","year":"2011","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis","volume":"365","author":"DV Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy","volume":"18","author":"MA French","year":"2004","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis","volume":"10","author":"M M\u00fcller","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref11","first-page":"1282","article-title":"Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis","volume":"11","author":"W Burman","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","article-title":"Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa","volume":"21","author":"SD Lawn","year":"2007","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"G Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(13)70007-0","article-title":"Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial","volume":"13","author":"M Bonnet","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref15","article-title":"Treatment of tuberculosis: guidelines for national programs","year":"2010"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1545109710361537","article-title":"Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings","volume":"9","author":"I Eshun-Wilson","year":"2010","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e40623","DOI":"10.1371\/journal.pone.0040623","article-title":"Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa","volume":"7","author":"LJ Haddow","year":"2012","journal-title":"PLOS ONE"},{"key":"ref18","first-page":"2011","article-title":"Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV\/AIDS patients receiving HAART","author":"S Karmakar","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/0003-4819-157-5-201209040-00004","article-title":"The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial","volume":"157","author":"K Naidoo","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3851\/IMP2108","article-title":"Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection","volume":"17","author":"W Worodria","year":"2012","journal-title":"Antivir Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QAI.0b013e3182255dc2","article-title":"Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB\/HIV patients commencing antiretroviral therapy","volume":"58","author":"W Worodria","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","first-page":"946","article-title":"Tuberculosis immune reconstitution inflammatory syndrome in countries with limited resources","volume":"10","author":"R Colebunders","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2334-13-27","article-title":"Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic","volume":"13","author":"M Bastard","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/mja12.10089","article-title":"Immune reconstitution inflammatory syndrome: immune restoration disease 20 years on","volume":"196","author":"MA French","year":"2012","journal-title":"Med J Aust"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1413-8670(11)70250-1","article-title":"Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients","volume":"15","author":"D Dibyendu","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/QAD.0b013e32832f7b59","article-title":"Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"23","author":"W Manosuthi","year":"2009","journal-title":"AIDS"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"G Meintjes","year":"2010","journal-title":"AIDS"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11904-012-0129-5","article-title":"Management of the immune reconstitution inflammatory syndrome","volume":"9","author":"G Meintjes","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e47542","DOI":"10.1371\/journal.pone.0047542","article-title":"Causes of death on antiretroviral therapy: a post-mortem study from South Africa","volume":"7","author":"EB Wong","year":"2012","journal-title":"PLOS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2006.01.002","article-title":"Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy","volume":"53","author":"W Manosuthi","year":"2006","journal-title":"J Infect"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/j.ijid.2011.02.007","article-title":"Impact of the immune reconstitution inflammatory syndrome (IRIS) on mortality and morbidity in HIV-infected patients in Mexico","volume":"15","author":"I Hoyo-Ulloa","year":"2011","journal-title":"Int J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/QAD.0b013e3283511e91","article-title":"Immune reconstitution inflammatory syndrome: incidence and implications for mortality","volume":"26","author":"RM Novak","year":"2012","journal-title":"AIDS"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1545109712457711","article-title":"Clinical outcomes among HIV\/Tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India","volume":"12","author":"N Kumarasamy","year":"2013","journal-title":"J Int Assoc Provid AIDS Care"}],"updated-by":[{"DOI":"10.1371\/annotation\/15d01128-2495-4b95-8fe8-8702190fdb0e","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T04:40:59Z","timestamp":1647751259000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084585"}},"subtitle":[],"editor":[{"given":"Wenzhe","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,18]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084585","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,18]]}}}